We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
CD47 Protein Products for Cancer & Cardiovascular Research
Product News

CD47 Protein Products for Cancer & Cardiovascular Research

CD47 Protein Products for Cancer & Cardiovascular Research
Product News

CD47 Protein Products for Cancer & Cardiovascular Research

Image Credit: AMSBIO

Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "CD47 Protein Products for Cancer & Cardiovascular Research"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO has announced a new range of CD47-relevant productssuitable for rapid high throughput screening studies.

CD47, or Integrin associated protein (IAP), is a transmembrane protein that in humans is encoded by the CD47 gene. Studies have established that CD47 is involved in a range of cellular processes, including apoptosis, proliferation, adhesion and migration.  Furthermore, CD47 is known to be a key regulator of tissue homeostasis, and is also involved in a variety of diseases ranging from atherosclerosis to cancer. Given its significant role in pathogenesis of cancer and cardiovascular diseases, CD47 signaling has been heavily investigated for new targeted therapeutics.


The unique set of CD47-relevant products from AMSBIO includes human CD47 protein and multiple avi tag pre-biotinylated proteins. Derived from Human (HEK 293) cells, AMSBIO CD47 protein products demonstrate superb bioactivity, high detection sensitivity and authentic post translational modification and protein conformation. The new AMSBIO CD47 protein kits are supplied as pairs of products that can be easily adapted to ELISA, AlphaLISA™ and MSD platforms to facilitate rapid and easy screening of the neutralizing compound.


Advertisement